Clinical Trials
3 trialsNCT06815575 2026-06-02
A Safety and Pharmacokinetics Study of RC220 Combined With Doxorubicin in Adult Participants With Solid Tumours.
Racura Oncology Ltd
Phase 1 Recruiting
NCT07446855 2026-05-26
PARTHENON
AstraZeneca
Phase 1/2 Recruiting
NCT07160725 2026-05-15
A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting